![Favorite pages[Japanese page]](/files/000137013.png){kind=small}
](/files/000137010.png){kind=small}
Here begins the text.
Pmda Pharmaceuticals and Medical Devices Agency
What's newBack number
October 22, 2021PMDA Risk Communication: Atezolizumab (genetical recombination) posted
- October 21, 2021ICH Quality Forum updated
- October 21, 2021Notifications and Administrative Notices: English Translations of Guidelines for Bioequivalence Studies of Generic Products
- October 20, 2021PMDA-ATC with National Cancer Center MRCT Webinar 2022
- October 18, 2021PDG October 2021 Press Release posted
- October 15, 2021Revisions of PRECAUTIONS: Coronavirus modified uridine RNA vaccine (SARS-CoV-2)(Comirnaty intramuscular injection) etc. posted
- October 13, 2021English Translation of Review Report: COVID-19 Vaccine Moderna (Report on Special Approval for Emergency)
- October 13, 2021List of Approved Products (New Drugs): FY 2021 (April 2021 - August 2021)
- October 21, 2021Notifications and Administrative Notices: English Translations of Guidelines for Bioequivalence Studies of Generic Products
- October 13, 2021English Translation of Review Report: COVID-19 Vaccine Moderna (Report on Special Approval for Emergency)
- October 13, 2021List of Approved Products (New Drugs): FY 2021 (April 2021 - August 2021)
- Currently, there is no applicable information.
- October 18, 2021PDG October 2021 Press Release posted
- Currently, there is no applicable information.
